DIPG-78. REVERTANCE OF THE H3K27M MUTATION RESCUES CHROMATIN MARKS NECESSARY FOR ONCOGENESIS IN DIFFUSE MIDLINE GLIOMA

por Nesvick, Cody, Day, Charles, Zhang, Liang, Hinchcliffe, Edward, Daniels, David
Publicado 2020

Asymptomatic superficial siderosis after posterior fossa tumor resection: illustrative case

por Goyal, Anshit, Nesvick, Cody L., Spear, Joshua A., Daniels, David J.
Publicado 2021

ATRT-07. DEFINING LOST AND GAINED TRANSCRIPTIONAL REGULATORY NETWORKS IN ATYPICAL TERATOID RHABDOID TUMOR

por Nesvick, Cody, Zhang, Liang, Wixom, Alex, Hamdan, Feda, Johnsen, Steven, Daniels, David
Publicado 2021

IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma

por Rechberger, Julian S., Porath, Kendra A., Zhang, Liang, Nesvick, Cody L., Schrecengost, Randy S., Sarkaria, Jann N., Daniels, David J.
Publicado 2022

A novel germline gain-of-function HIF2A mutation in hepatocellular carcinoma with polycythemia

por Yu, Jiong, Shi, Xiaowei, Yang, Chunzhang, Bullova, Petra, Hong, Christopher S., Nesvick, Cody L., Dmitriev, Pauline, Pacak, Karel, Zhuang, Zhengping, Cao, Hongcui, Li, Lanjuan
Publicado 2020

Tumors displaying hybrid schwannoma and neurofibroma features in patients with neurofibromatosis type 2

por Montgomery, Blake K., Alimchandani, Meghna, Mehta, Gautam U., Dewan, Ramita, Nesvick, Cody L., Miettinen, Markku, Heiss, John D., Asthagiri, Ashok R., Quezado, Martha, Germanwala, Anand V.
Publicado 2016

Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time

por Power, Erica A, Rechberger, Julian S, Zhang, Liang, Oh, Ju-Hee, Anderson, Jacob B, Nesvick, Cody L, Ge, Jizhi, Hinchcliffe, Edward H, Elmquist, William F, Daniels, David J
Publicado 2023

Gliosarcoma with Primary Skull Base Invasion

por Nguyen, Quoc-Bao D., Perry, Avital, Graffeo, Christopher S., Nesvick, Cody L., Raghunathan, Aditya, Jentoft, Mark E., O'Neill, Brian P., Morris, Padraig P., Morris, Jonathan M., Van Gompel, Jamie J.
Publicado 2016

Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha

por Zhang, Chao, Yang, Chunzhang, Feldman, Michael J., Wang, Herui, Pang, Ying, Maggio, Dominic M., Zhu, Dongwang, Nesvick, Cody L., Dmitriev, Pauline, Bullova, Petra, Chittiboina, Prashant, Brady, Roscoe O., Pacak, Karel, Zhuang, Zhengping
Publicado 2017

Hypotaurine evokes a malignant phenotype in glioma through aberrant hypoxic signaling

por Gao, Peng, Yang, Chunzhang, Nesvick, Cody L., Feldman, Michael J., Sizdahkhani, Saman, Liu, Huailei, Chu, Huiying, Yang, Fengxu, Tang, Ling, Tian, Jing, Zhao, Shiguang, Li, Guohui, Heiss, John D., Liu, Yang, Zhuang, Zhengping, Xu, Guowang
Publicado 2016

STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma

por Zhang, Liang, Nesvick, Cody L, Day, Charlie A, Choi, Jonghoon, Lu, Victor M, Peterson, Timothy, Power, Erica A, Anderson, Jacob B, Hamdan, Feda H, Decker, Paul A, Simons, Renae, Welby, John P, Siada, Ruby, Ge, Jizhi, Kaptzan, Tatiana, Johnsen, Steven A, Hinchcliffe, Edward H, Daniels, David J
Publicado 2022

Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy

por Xu, Hui, Rahimpour, Shervin, Nesvick, Cody L., Zhang, Xu, Ma, Jingyun, Zhang, Min, Zhang, Ge, Wang, Li, Yang, Chunzhang, Hong, Christopher S., Germanwala, Anand V., Elder, J. Bradley, Ray-Chaudhury, Abhik, Yao, Yu, Gilbert, Mark R., Lonser, Russell R., Heiss, John D., Brady, Roscoe O., Mao, Ying, Qin, Jianhua, Zhuang, Zhengping
Publicado 2015